The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory

Frontiers in Pharmacology

Volumn 6, Issue Aug, 2015, Pages

  Stiedl, Oliver ^a   Pappa, Elpiniki ^a   Konradsson Geuken, Åsa ^b   Ögren, Sven Ove ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 HT1A receptor ligands; 5 HT7 receptor ligands; Emotional learning; Fear conditioning; Fear memory; Passive avoidance; Serotonin

Indexed keywords

1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE; 1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 DIPROPYLAMINO 1,3,4,5 TETRAHYDROBENZ[CD]INDOLE 6 CARBOXAMIDE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALNESPIRONE; BEFIRADOL; BINOSPIRONE; BUSPIRONE; F 13714; F 15599; FLESINOXAN; IPSAPIRONE; LECOZOTAN; LY 2287295; LY 426965; MP 3022; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NALUZOTAN; OSEMOZOTAN; REPINOTAN; ROBALZOTAN; SB 649915; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SPIPERONE; TANDOSPIRONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BRAIN NERVE CELL; CELL ACTIVITY; COGNITION; EMOTIONAL LEARNING; EMOTIONAL MEMORY; EPIGENETICS; HIPPOCAMPUS; HUMAN; LEARNING AND MEMORY TEST; MEMORY CONSOLIDATION; NEUROTRANSMISSION; NONHUMAN; PASSIVE AVOIDANCE; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84940992487     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00162     Document Type: Review

References (161)

1. Ahlenius, S., Larsson, K., and Wijkström, A. (1991). Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur. J. Pharmacol. 200, 259-266. doi: 10.1016/0014-2999(91)90580-J
2. Allen, A. R., Singh, A., Zhuang, Z. P., Kung, M. P., Kung, H. F., and Lucki, I. (1997). The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors. Pharmacol. Biochem. Behav. 57, 301-307. doi: 10.1016/S0091-3057(96)00339-5
3. Almada, R. C., Borelli, K. G., Albrechet-Souza, L., and Brandão, M. L. (2009). Serotonergic mechanisms of the median raphe nucleus-dorsal hippocampus in conditioned fear: output circuit involves the prefrontal cortex and amygdale. Behav. Brain Res. 203, 279-287. doi: 10.1016/j.bbr.2009.05.017
4. Artigas, F. (2015). Developments in the field of antidepressants, where do we go now?. Eur. Neuropsychopharmacol. 25, 657-670. doi: 10.1016/j.euroneuro.2013.04.013
5. Artigas, F., Celada, P., Laruelle, M., and Adell, A. (2001). How does pindolol improve antidepressant action?. Trends Pharmacol. Sci. 22, 224-228. doi: 10.1016/S0165-6147(00)01682-5
6. Arvidsson, L. E., Hacksell, U., Nilsson, J. L., Hjorth, S., Carlsson, A., Lindberg, P., et al. (1981). 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J. Med. Chem. 24, 9219-9223. doi: 10.1021/jm00140a002
7. Assié, M. B., Lomenech, H., Ravailhe, V., Faucillon, V., and Newman-Tancredi, A. (2006). Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. Br. J. Pharmacol. 149, 170-178. doi: 10.1038/sj.bjp.0706859
8. Baarendse, P. J. J., van Grootheest, G., Jansen, R. F., Pieneman, A. W., Ögren, S. O., Verhage, M., et al. (2008). Differential involvement of the dorsal hippocampus in passive avoidance in C57BL/6J and DBA/2J mice. Hippocampus 18, 11-19. doi: 10.1002/hipo.20356
9. Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A., and Weinshank, R. L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268, 23422-23426.
10. Barnes, N. M., and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152. doi: 10.1016/S0028-3908(99)00010-6
11. Bauer, E. P. (2014). Serotonin in fear conditioning processes. Behav. Brain Res. 15, 68-77. doi: 10.1016/j.bbr.2014.07.028
12. Becker, O. M., Dhanoa, D. S., Marantz, Y., Chen, D., Shacham, S., Cheruku, S., et al. (2006). An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. J. Med. Chem. 49, 3116-3135. doi: 10.1021/jm0508641
13. Béïque, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., and Andrade, R. (2007). Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 104, 9870-9875. doi: 10.1073/pnas.0700436104
14. Berger, M., Gray, J. A., and Roth, B. L. (2009). The expanded biology of serotonin. Annu. Rev. Med. 60, 355-366. doi: 10.1146/annurev.med.60.042307.110802
15. Bertrand, F., Lehmann, O., Galani, R., Lazarus, C., Jeltsch, H., and Cassel, J. C. (2001). Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats. Pharmacol. Biochem. Behav. 68, 647-660. doi: 10.1016/S0091-3057(01)00448-8
16. Berumen, L. C., Rodríguez, A., Miledi, R., and García-Alcocer, G. (2012). Serotonin receptors in hippocampus. Sci. World J. 2012:823493. doi: 10.1100/2012/823493
17. Bickmeyer, U., Heine, M., Manzke, T., and Richter, D. W. (2002). Differential modulation of Ih by 5-HT receptors in mouse CA1 hippocampal neurons. Eur. J. Neurosci. 16, 209-218. doi: 10.1046/j.1460-9568.2002.02072.x
18. Blier, P., and Ward, N. M. (2003). Is there a role for 5-HT1A agonists in the treatment of depression?. Biol. Psychiatry 53, 193-203. doi: 10.1016/S0006-3223(02)01643-8
19. Bockaert, J., Claeysen, S., Bécamel, C., Dumuis, A., and Marin, P. (2006). Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tiss. Res. 326, 553-572. doi: 10.1007/s00441-006-0286-1
20. Bonaventure, P., Nepomuceno, D., Hein, L., Sutcliffe, J. G., Lovenberg, T., and Hedlund, P. B. (2004). Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine7 receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with 2 adrenergic receptors. Neuroscience 124, 901-911. doi: 10.1016/j.neuroscience.2004.01.014
21. Borelli, K. G., Gárgaro, A. C., dos Santos, J. M., and Brandão, M. L. (2005). Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning. Neurosci. Lett. 387, 105-110. doi: 10.1016/j.neulet.2005.07.031
22. Bosker, F. J., Folgering, J. H., Gladkevich, A. V., Schmidt, A., van der Hart, M. C., Sprouse, J., et al. (2009). Antagonism of 5-HT1A receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT7 receptors. J. Neurochem. 108, 1126-1135. doi: 10.1111/j.1471-4159.2008.05850.x
23. Bradley, P. B., Engle, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemis, D. N., et al. (1986). Proposals for the classification and nomenclature of functional receptors of 5-hydroxytryptamine. Neuropharmacology 25, 563-576. doi: 10.1016/0028-3908(86)90207-8
24. Brenchat, A., Romero, L., García, M., Pujol, M., Burgueño, J., Torrens, A., et al. (2009). 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 141, 239-247. doi: 10.1016/j.pain.2008.11.009
25. Cahill, L., and McGaugh, J. L. (1998). Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci. 21, 294-299. doi: 10.1016/S0166-2236(97)01214-9
26. Carli, M., Balducci, C., Millan, M. J., Bonalumi, P., and Samanin, R. (1999). S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Br. J. Pharmacol. 128, 1207-1214. doi: 10.1038/sj.bjp.0701632
27. Carli, M., Lazarova, M., Tatarczynska, E., and Samanin, R. (1992). Stimulation of 5-HT1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze. Brain Res. 595, 50-56. doi: 10.1016/0006-8993(92)91451-J
28. Celada, P., Puig, M. V., and Artigas, F. (2013). Serotonin modulation of cortical neurons and networks. Front. Integr. Neurosci. 7:25. doi: 10.3389/fnint.2013.00025
29. Charnay, Y., and Léger, L. (2010). Brain serotonergic circuitries. Dialogues Clin. Neurosci. 12, 471-487.
30. Choi, J. Y., Shin, S., Lee, M., Jeon, T. J., Seo, Y., Kim, C. H., et al. (2014). Acute physical stress induces the alteration of the serotonin 1A receptor density in the hippocampus. Synapse 68, 363-368. doi: 10.1002/syn.21748
31. Clarke, W. P., Yocca, F. D., and Maayani, S. (1996). Lack of 5-hydroxytryptamine 1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. J. Pharmacol. Exp. Ther. 277, 1259-1266.
32. Costa, L., Trovato, C., Musumeci, S. A., Catania, M. V., and Ciranna, L. (2012). 5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Hippocampus 22, 790-801. doi: 10.1002/hipo.20940
33. Day, B. K., Pomerleau, F., Burmeister, J. J., Huettl, P., and Gerhardt, G. A. (2006). Microelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain. J. Neurochem. 96, 1626-1635. doi: 10.1111/j.1471-4159.2006.03673.x
34. De Vivo, M., and Maayani, S. (1986). Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238, 248-253.
35. De Vry, J., Schohe-Loop, R., Heine, H. G., Greuel, J. M., Mauler, F., Schmidt, B., et al. (1998). Characterization of the aminomethylchroman derivative BAY×3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. J. Pharmacol. Exp. Ther. 284, 1082-1094.
36. Del Tredici, A. L., Schiffer, H. H., Burstein, E. S., Lameh, J., Mohell, N., Hacksell, U., et al. (2004). Pharmacology of polymorphic variants of the human 5-HT1A receptor. Biochem. Pharmacol. 67, 479-490. doi: 10.1038/sj.bjp.0705576
37. Den Boer, J. A., Bosker, F. J., and Slaap, B. R. (2000). Serotonergic drugs in the treatment of depressive and anxiety disorders. Hum. Psychopharmacol. 15, 315-336. doi: 10.1002/1099-1077(200007)15:5<315::AID-HUP204>3.0.CO;2-Y
38. Deseure, K., Koek, W., Colpaert, F. C., and Adriaensen, H. (2002). The 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. Eur. J. Pharmacol. 456, 51-57. doi: 10.1016/j.bcp.2003.09.030
39. Elvander-Tottie, E., Eriksson, T. M., Sandin, J., and Ögren, S. O. (2009). 5-HT1A and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning. Hippocampus 19, 1187-1198. doi: 10.1002/hipo.20596
40. Eriksson, T. M., Holst, S., Stan, T. L., Hager, T., Sjögren, B., Ögren, S. O., et al. (2012). 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology 63, 1150-1160. doi: 10.1016/j.neuropharm.2012.06.061
41. Eriksson, T. M., Golkar, A., Ekström, J. C., Svenningsson, P., and Ögren, S. O. (2008). 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT1A receptor stimulation on contextual learning in mice. Eur. J. Pharmacol. 596, 107-110. doi: 10.1016/j.ejphar.2008.08.026
42. Errico, M., Crozier, R. A., Plummer, M. R., and Cowen, D. S. (2001). 5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. Neuroscience 102, 361-367. doi: 10.1016/S0306-4522(00)00460-7
43. Ferreira, R., and Nobre, M. J. (2014). Conditioned fear in low-and high-anxious rats is differentially regulated by cortical subcortical and midbrain 5-HT receptors. Neuroscience 268, 159-168. doi: 10.1016/j.neuroscience.2014.03.005
44. Filip, M., and Przegalinski, E. (1996). Effects of MP-3022 on the 8-OH-DPAT-induced discriminative stimulus in rats. Pol. J. Pharmacol. 48, 397-402.
45. Fletcher, A., Forster, E. A., Bill, D. J., Brown, G., Cliffe, I. A., Hartley, J. E., et al. (1996). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5 HT1A receptor antagonist. Behav. Brain Res. 73, 337-353. doi: 10.1016/0166-4328(96)00118-0
46. Forbes, I. T., Dabbs, S., Duckworth, D. M., Jennings, A. J., King, F. D., Lovell, P. J., et al. (1998). (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist. J. Med. Chem. 41, 655-657. doi: 10.1021/jm970519e
47. Gozlan, H., El Mestikawy, S., Pichat, L., Glowinski, J., and Hamon, M. (1983). Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305, 140-142. doi: 10.1038/305140a0
48. Grasby, P. M., Sharp, T., Allen, T., and Grahame-Smith, D. G. (1992). The putative 5-HT1A antagonist BMY 7378 blocks 8-OH-DPAT-induced changes in local cerebral glucose utilization in the conscious rat. Neuropharmacology 31, 547-551. doi: 10.1016/0028-3908(92)90186-S
49. Greuel, J. M., and Glaser, T. (1992). The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur. J. Pharmacol. 211, 211-219. doi: 10.1016/0014-2999(92)90531-8
50. Griebel, G., Misslin, R., Pawlowski, M., Guardiola Lemaitre, B., Guillaumet, G., and Bizot-Espiard, J. (1992). Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice. NeuroReport 3, 84-86. doi: 10.1097/00001756-199201000-00022
51. Groenink, L., Joordens, R. J., Hijzen, T. H., Dirks, A., and Olivier, B. (2000). Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle. NeuroReport 11, 2285-2288. doi: 10.1097/00001756-200007140-00043
52. Hadrava, V., Blier, P., Dennis, T., Ortemann, C., and de Montigny, C. (1995). Characterization of 5-hydroxytryptamine 1A properties of flesinoxan: in vivo electrophysiology and hypothermia study. Neuropharmacology 34, 1311-1326. doi: 10.1016/0028-3908(95)00098-Q
53. Hager, T., Jansen, R. F., Pieneman, A. W., Manivannan, S. N., Golani, I., van der Sluis, S., et al. (2014). Display of individuality in avoidance behavior and risk assessment of inbred mice. Front. Behav. Neurosci. 8:314. doi: 10.3389/fnbeh.2014.00314
54. Hajós-Korcsok, E., McQuade, R., and Sharp, T. (1999). Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (±)-MDL 73005EF and its enantiomers. Neuropharmacology 38, 299-306. doi: 10.1016/S0028-3908(98)00175-0
55. Hannon, J., and Hoyer, D. (2008). Molecular biology of 5-HT receptors. Behav. Brain Res. 195, 198-213. doi: 10.1016/j.bbr.2008.03.020
56. Heisler, L. K., Chu, H. M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., et al. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U.S.A. 95, 15049-15054. doi: 10.1073/pnas.95.25.15049
57. Hervas, I., and Artigas, F. (1998). Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur. J. Pharmacol. 358, 9-18. doi: 10.1016/S0014-2999(98)00579-2
58. Heusler, P., Palmier, C., Tardif, S., Bernois, S., Colpaert, F. C., and Cussac, D. (2010). [3H]-F13640, a novel, selective and high-efficacy serotonin 5-HT1A receptor agonist radioligand. Naunyn Schmiedebergs Arch. Pharmacol. 382, 321-330. doi: 10.1007/s00210-010-0551-4
59. Hirst, W. D., Andree, T. H., Aschmies, S., Childers, W. E., Comery, T. A., Dawson, L. A., et al. (2008). Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405). J. Pharmacol. Exp. Ther. 325, 134-145. doi: 10.1124/jpet.107.133082
60. Hjorth, S., and Carlsson, A. (1982). Buspirone: effects on central monoaminergic transmission-possible relevance to animal experimental and clinical findings. Eur. J. Pharmacol. 83, 299-303. doi: 10.1016/0014-2999(82)90265-5
61. Holz, G. G., Kang, G., Harbeck, M., Roe, M. W., and Chepurny, O. G. (2006). Cell physiology of cAMP sensor Epac. J. Physiol. 577, 5-15. doi: 10.1113/jphysiol.2006.119644
62. Homberg, J. R. (2012). Serotonergic modulation of conditioned fear. Scientifica 2012, 1-16. doi: 10.6064/2012/821549
63. Horisawa, T., Ishibashi, T., Nishikawa, H., Enomoto, T., Toma, S., Ishiyama, T., et al. (2011). The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone. Behav. Brain Res. 220, 83-90. doi: 10.1016/j.bbr.2011.01.034
64. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., et al. (1994). International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
65. Hoyer, D., Hannon, J. P., and Martin, G. R. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71, 533-554. doi: 10.1016/S0091-3057(01)00746-8
66. Hoyer, D., and Martin, G. (1997). 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36, 419-428. doi: 10.1016/S0028-3908(97)00036-1
67. Hunt, S. P., and Lovick, T. A. (1982). The distribution of serotonin, met-enkephalin and beta-lipotropin-like immunoreactivity in neuronal perikarya of the cat brainstem. Neurosci. Lett. 30, 139-145. doi: 10.1016/0304-3940(82)90286-5
68. Ikeda, M., Iwata, N., Kitajima, T., Suzuki, T., Yamanouchi, Y., Kinoshita, Y., et al. (2006). Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology 31, 866-871. doi: 10.1038/sj.npp.1300901
69. Ishimura, K., Takeuchi, Y., Fujiwara, K., Tominaga, M., Yoshioka, H., and Sawada, T. (1988). Quantitative analysis of the distribution of serotonin-immunoreactive cell bodies in the mouse brain. Neurosci. Lett. 91, 265-270. doi: 10.1016/0304-3940(88)90691-X
70. Jackson, D. M., Bengtsson, A., Johansson, C., Cortizo, L., and Ross, S. B. (1994). Development of tolerance to 8-OH-DPAT induced blockade of acquisition of a passive avoidance response. Neuropharmacology 33, 1003-1009. doi: 10.1016/0028-3908(94)90159-7
71. Johansson, L., Sohn, D., Thorberg, S. O., Jackson, D. M., Kelder, D., Larsson, L. G., et al. (1997). The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. J. Pharmacol. Exp. Ther. 283, 216-225.
72. Kalliokoski, O., Teilmann, A. C., Jacobsen, K. R., Abelson, K. S., and Hau, J. (2014). The lonely mouse-single housing affects serotonergic signaling integrity measured by 8-OH-DPAT-induced hypothermia in male mice. PLoS ONE 9:e111065. doi: 10.1371/journal.pone.0111065
73. Kehr, J., Hu, X. J., Yoshitake, T., Wang, F. H., Osborne, P., Stenfors, C., et al. (2010). The selective 5-HT1A receptor antagonist NAD-299 increases acetylocholine release but not the extracellular glutamate levels in the frontal cortex and hippocampus of awake rat. Eur. Neupsychopharmacol. 20, 487-500. doi: 10.1016/j.euroneuro.2010.03.003
74. Kia, H. K., Brisorgueil, M. J., Hamon, M., Calas, A., and Verge, D. (1996). Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. J. Neurosci. Res. 46, 697-708. doi: 10.1002/(SICI)1097-4547(19961215)46:6<697::AID-JNR7>3.0.CO;2-A
75. Kikuchi, C., Nagaso, H., Hiranuma, T., and Koyama, M. (1999). Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor. J. Med. Chem. 42, 533-535. doi: 10.1021/jm980519u
76. Kobe, F., Guseva, D., Jensen, T. P., Wirth, A., Renner, U., Hess, D., et al. (2012). 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J. Neurosci. 32, 2915-2930. doi: 10.1523/JNEUROSCI.2765-11.2012
77. Konradsson-Geuken, A., Gash, C. R., Alexander, K., Pomerleau, F., Huettl, P., Gerhardt, G. A., et al. (2009). Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats. Synapse 63, 1069-1082. doi: 10.1002/syn.20693
78. Kung, H. F., Kung, M. P., Clarke, W., Maayani, S., and Zhuang, Z. P. (1994). A potential 5-HT1A receptor antagonist: p-MPPI. Life Sci. 55, 1459-1462. doi: 10.1016/0024-3205(94)00686-5
79. Kung, H. F., Stevenson, D. A., Zhuang, Z. P., Kung, M. P., Frederick, D., and Hurt, S. D. (1996). New 5-HT1A receptor antagonist: [3H]p-MPPF. Synapse 23, 344-346. doi: 10.1002/(SICI)1098-2396(199608)23:4<344::AID-SYN13>3.0.CO;2-X
80. LeDoux, J. E. (2000). Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155-184. doi: 10.1146/annurev.neuro.23.1.155
81. Leopoldo, M. (2004). Serotonin7 receptors (5-HT7Rs) and their ligands. Curr. Med. Chem. 11, 629-661. doi: 10.2174/0929867043455828
82. Leopoldo, M., Lacivita, E., Berardi, F., Perrone, R., and Hedlund, P. B. (2011). Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol. Ther. 129, 120-148. doi: 10.1016/j.pharmthera.2010.08.013
83. Leopoldo, M., Lacivita, E., De Giorgio, P., Fracasso, C., Guzzetti, S., Caccia, S., et al. (2008). Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III J. Med. Chem. 51, 5813-5822. doi: 10.1021/jm800615e
84. Li, X., Inoue, T., Abekawa, T., Weng, S., Nakagawa, S., Izumi, T., et al. (2006). 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. Eur. J. Pharmacol. 532, 74-80. doi: 10.1016/j.ejphar.2005.12.008
85. Lin, S. L., Johnson-Farley, N. N., Lubinsky, D. R., and Cowen, D. S. (2003). Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J. Neurochem. 87, 1076-1085. doi: 10.1046/j.1471-4159.2003.02076.x
86. Lovell, P. J., Bromidge, S. M., Dabbs, S., Duckworth, D. M., Forbes, I. T., Jennings, A. J., et al. (2000). A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem. 10, 342-345. doi: 10.1021/jm990412m
87. Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., et al. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11, 449-458. doi: 10.1016/0896-6273(93)90149-L
88. Lucki, I. J. (1991). Behavioral studies of serotonin receptor agonists as antidepressant drugs. Clin. Psychiatry 52, 24-31.
89. Lüttgen, M., Ögren, S. O., and Meister, B. (2005a). 5-HT1A receptor mRNA and immunoreactivity in the rat medial septum/diagonal band of Broca-relationships to GABAergic and cholinergic neurons. J. Chem. Neuroanat. 29, 93-111. doi: 10.1016/j.jchemneu.2004.09.001
90. Lüttgen, M., Elvander, E., Madjid, N., and Ögren, S. O. (2005b). Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat. Neuropharmacology 48, 830-852. doi: 10.1016/j.neuropharm.2005.01.007
91. Madjid, N., Tottie, E. E., Lüttgen, M., Meister, B., Sandin, J., Kuzmin, A., et al. (2006). 5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms. J. Pharmacol. Exp. Ther. 316, 581-591. doi: 10.1124/jpet.105.092262
92. Mahé, C., Loetscher, E., Feuerbach, D., Müller, W., Seiler, M. P., and Schoeffter, P. (2004). Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur. J. Pharmacol. 495, 97-102. doi: 10.1016/j.ejphar.2004.05.033
93. Martin-Cora, F. J., and Pazos, A. (2004). Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. Br. J. Pharmacol. 141, 92-104. doi: 10.1038/sj.bjp.0705576
94. Matsuda, T., Yoshikawa, T., Suzuki, M., Asano, S., Somboonthum, P., Takuma, K., et al. (1995). Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors. Jpn. J. Pharmacol. 69, 357-366. doi: 10.1254/jjp.69.357
95. Maurel, J. L., Autin, J. M., Funes, P., Newman-Tancredi, A., Colpaert, F., and Vacher, B. (2007). High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity. J. Med. Chem. 50, 5024-5033. doi: 10.1021/jm070714l
96. Mendelson, S. D., Quartermain, D., Francisco, T., and Shemer, A. (1993). 5-HT1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism. Eur. J. Pharmacol. 236, 177-182. doi: 10.1016/0014-2999(93)90587-8
97. Meneses, A. (2004). Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav. Brain Res. 155, 275-282. doi: 10.1016/j.bbr.2004.04.026
98. Meneses, A., Perez-García, G., Liy-Salmeron, G., Ponce-López, T., Lacivita, E., and Leopoldo, M. (2015). 5-HT7 receptor activation: procognitive and antiamnesic effects. Psychopharmacology 232, 595-603. doi: 10.1007/s00213-014-3693-0
99. Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., et al. (2012). Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat. Rev. Drug. Discov. 11, 141-168. doi: 10.1038/nrd3628
100. Millan, M. J., Rivet, J. M., Canton, H., Lejeune, F., Gobert, A., Widdowson, P., et al. (1993). S 15535, a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively. Eur. J. Pharmacol. 230, 99-102. doi: 10.1016/0014-2999(93)90416-F
101. Minabe, Y., Schechter, L., Hashimoto, K., Shirayama, Y., and Ashby, C. R. Jr. (2003). Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 50, 181-190. doi: 10.1002/syn.10255
102. Misane, I., Johansson, C., and Ögren, S. O. (1998). Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br. J. Pharmacol. 125, 499-509. doi: 10.1038/sj.bjp.0702098
103. Misane, I., Kruis, A., Pieneman, A. W., Ögren, S. O., and Stiedl, O. (2013). GABAA receptor activation in the CA1 area of the dorsal hippocampus impairs consolidation of conditioned contextual fear in C57BL/6J mice. Behav. Brain Res. 238, 160-169. doi: 10.1016/j.bbr.2012.10.027
104. Misane, I., and Ögren, S. O. (2000). Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22, 168-190. doi: 10.1016/S0893-133X(99)00109-8
105. Mishra, D., Harrison, N. R., Gonzales, C. B., Schilström, B., and Konradsson-Geuken, Å. (2015). Effects of age and acute ethanol on glutamatergic neurotransmission in the medial prefrontal cortex of freely moving rats using enzyme-based microelectrode amperometry. PLoS ONE 10:e0125567. doi: 10.1371/journal.pone.0125567
106. Monti, J. M., Leopoldo, M., and Jantos, H. (2008). The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav. Brain Res. 191, 184-189. doi: 10.1016/j.bbr.2008.03.025
107. Moreau, J. L., Griebel, G., Jenck, F., Martin, J. R., Widmer, U., and Haefely, W. E. (1992). Behavioral profile of the 5-HT1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Res. Bull. 29, 901-904. doi: 10.1016/0361-9230(92)90163-R
108. Naumenko, V. S., Popova, N. K., Lacivita, E., Leopoldo, M., and Ponimaskin, E. G. (2014). Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders. CNS Neurosci. Ther. 20, 582-590. doi: 10.1111/cns.12247
109. Newman-Tancredi, A., Martel, J. C., Assié, M. B., Buritova, J., Lauressergues, E., Cosi, C., et al. (2009). Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br. J. Pharmacol. 156, 338-353. doi: 10.1111/j.1476-5381.2008.00001.x
110. Nichols, D. E., and Nichols, C. D. (2008). Serotonin receptors. Chem. Rev. 108, 1614-1641. doi: 10.1021/cr078224o
111. Norum, J. H., Hart, K., and Levy, F. O. (2003). Ras-dependent ERK activation by the human Gs-coupled serotonin receptors 5-HT4(b) and 5-HT7(a). J. Biol. Chem. 278, 3098-3104. doi: 10.1074/jbc.M206237200
112. Ögren, S. O., Eriksson, T. M., Elvander-Tottie, E., D'Addario, C., Ekström, J. C., Svenningsson, P., et al. (2008). The role of 5-HT1A receptors in learning and memory. Behav. Brain Res. 195, 54-77. doi: 10.1016/j.bbr.2008.02.023
113. Ögren, S. O., and Stiedl, O. (2015). "Passive avoidance," in Encyclopedia of Psychopharmacology, 2nd Edn, eds I. P. Stolerman, H. Lawrence, and L. H. Price (Berlin: Springer), 1220-1228. doi: 10.1007/978-3-642-36172-2_160
114. Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., and Toth, M. (1998). Increased anxiety of mice lacking the serotonin 1A receptor. Proc. Natl. Acad. Sci. U.S.A. 95, 10734-10739. doi: 10.1073/pnas.95.18.10734
115. Passchier, J., van Waarde, A., Pieterman, R. M., Elsinga, P. H., Pruim, J., Hendrikse, H. N., et al. (2000). In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF. J. Nucl. Med. 41, 1830-1835.
116. Perez-García, G. S., and Meneses, A. (2005). Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Behav. Brain Res. 163, 136-140. doi: 10.1016/j.bbr.2005.04.014
117. Pike, V. W., McCarron, J. A., Lammertsma, A. A., Osman, S., Hume, S. P., Sargent, P. A., et al. (1996). Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635. Eur. J. Pharmacol. 301, R5-R7. doi: 10.1016/0014-2999(96)00079-9
118. Pitsikas, N., Rigamonti, A. E., Cella, S. G., and Muller, E. E. (2003). The 5-HT1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task. Brain Res. 983, 215-222. doi: 10.1016/S0006-8993(03)03091-9
119. Pittalà, V., Siracusa, M. A., Salerno, L., Romeo, G., Modica, M. N., Madjid, N., et al. (2015). Analysis of mechanisms for memory enhancement using novel and potent 5-HT1A receptor ligands. Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.04.017 [Epub ahead of print].
120. Pouzet, B., Didriksen, M., and Arnt, J. (2002). Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol. Biochem. Behav. 71, 655-665. doi: 10.1016/S0091-3057(01)00744-4
121. Quartermain, D., Clemente, J., and Shemer, A. (1993). 5-HT1A agonists disrupt memory of fear conditioning in mice. Biol. Psychiatry 33, 247-254. doi: 10.1016/0006-3223(93)90290-T
122. Raghupathi, R. K., Rydelek-Fitzgerald, L., Teitler, M., and Glennon, R. A. (1991). Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido) butyl]piperazine with reduced alpha 1-adrenergic affinity. J. Med. Chem. 34, 2633-2638. doi: 10.1021/jm00112a043
123. Rang, H. P., Ritter, J. M., Flower, R. J., and Henderson, G. (2015). Pharmacology, 8th Edn. (London: Elsevier Churchill Livingstone).
124. Rasmussen, K., Calligaro, D. O., Czachura, J. F., Dreshfield-Ahmad, L. J., Evans, D. C., Hemrick-Luecke, S. K., et al. (2000). The novel 5-hydroxytryptamine1A antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine. J. Pharmacol. Exp. Ther. 294, 688-700.
125. Raymond, J. R., Mukhin, Y. V., Gelasco, A., Turner, J., Collinsworth, G., Gettys, T. W., et al. (2001). Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 92, 179-212. doi: 10.1016/S0163-7258(01)00169-3
126. Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., et al. (2012). Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. Cell Sci. 15, 2486-2499. doi: 10.1242/jcs.101337
127. Riad, M., Garcia, S., Watkins, K. C., Jodoin, N., Doucet, E., Langlois, X., et al. (2000). Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417, 181-194. doi: 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A
128. Roberts, A. J., Krucker, T., Levy, C. L., Slanina, K. A., Sutcliffe, J. G., and Hedlund, P. B. (2004). Mice lacking 5-HT receptors show specific impairments in contextual learning. Eur. J. Neurosci. 19, 1913-1922. doi: 10.1111/j.1460-9568.2004.03288.x
129. Rotondo, A., Nielsen, D. A., Nakhai, B., Hulihan-Giblin, B., Bolos, A., and Goldman, D. (1997). Agonist promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor. Neuropsychopharmacology 17, 18-26. doi: 10.1016/S0893-133X(97)00021-3
130. Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., and Arrang, J. M. (1993). Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A. 90, 8547-8551. doi: 10.1073/pnas.90.18.8547
131. Sakaue, M., Ago, Y., Baba, A., and Matsuda, T. (2003). The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology 170, 73-79. doi: 10.1007/s00213-003-1515-x
132. Sarkisyan, G., and Hedlund, P. B. (2009). The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav. Brain Res. 202, 26-31. doi: 10.1016/j.bbr.2009.03.011
133. Savitz, J., Lucki, I., and Drevets, W. C. (2009). 5-HT1A receptor function in major depressive disorder. Prog. Neurobiol. 88, 17-31. doi: 10.1016/j.pneurobio.2009.01.009
134. Schechter, L. E., Smith, D. L., Rosenzweig-Lipson, S., Sukoff, S. J., Dawson, L. A., Marquis, K., et al. (2005). Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. J. Pharmacol. Exp. Ther. 314, 1274-1289. doi: 10.1124/jpet.105.086363
135. Schwarz, T., Beckermann, B., Buehner, K., Mauler, F., Schuhmacher, J., Seidel, D., et al. (2005). Pharmacokinetics of repinotan in healthy and brain injured animals. Biopharm. Drug Dispos. 26, 259-268. doi: 10.1002/bdd.458
136. Shimizu, H., Hirose, A., Tatsuno, T., Nakamura, M., and Katsube, J. (1987). Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate. Jpn. J. Pharmacol. 45, 493-500. doi: 10.1254/jjp.45.493
137. Siracusa, M. A., Salerno, L., Modica, M. N., Pittalà, V., Romeo, G., Amato, M. E., et al. (2008). Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands. J. Med. Chem. 51, 4529-4538. doi: 10.1021/jm800176x
138. Skirzewski, M., Hernandez, L., Schechter, L. E., and Rada, P. (2010). Acute lecozotan administration increases learning and memory in rats without affecting anxiety or behavioral depression. Pharmacol. Biochem. Behav. 95, 325-330. doi: 10.1016/j.pbb.2010.02.008
139. Sodickson, D. L., and Bean, B. P. (1998). Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: interactions among multiple receptors. J. Neurosci. 18, 8153-8162.
140. Starr, K. R., Price, G. W., Watson, J. M., Atkinson, P. J., Arban, R., Melotto, S., et al. (2007). SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology 32, 2163-2172. doi: 10.1038/sj.npp.1301341
141. Stenfors, C., Werner, T., and Ross, S. B. (1998). In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299. N.-S. Arch. Pharmacol. 357, 500-507. doi: 10.1007/PL00005199
142. Stiedl, O., Jansen, R. F., Pieneman, A. W., Ögren, S. O., and Meyer, M. (2009). Assessing aversive emotional states through the heart in mice: implications for cardiovascular dysregulation in affective disorders. Neurosci. Biobehav. Rev. 33, 181-190. doi: 10.1016/j.neubiorev.2008.08.015
143. Stiedl, O., Misane, I., Spiess, J., and Ögren, S. O. (2000a). Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J. Neurosci. 20, 8515-8527.
144. Stiedl, O., Birkenfeld, K., Palve, M., and Spiess, J. (2000b). Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav. Brain Res. 116, 157-168. doi: 10.1016/S0166-4328(00)00269-2
145. Swanson, S. P., and Catlow, J. (1992). Disposition of the novel serotonin agonist, LY228729, in monkeys and rats. Drug Metab. Dispos. 20, 102-107.
146. Takahashi, H., Nakashima, S., Ohama, E., Takeda, S., and Ikuta, F. (1986). Distribution of serotonin-containing cell bodies in the brainstem of the human fetus determined with immunohistochemistry using antiserotonin serum. Brain Dev. 8, 355-365. doi: 10.1016/S0387-7604(86)80055-9
147. Thomas, D. R., Atkinson, P. J., Hastie, P. G., Roberts, J. C., Middlemiss, D. N., and Price, G. W. (2002). [3H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues. Neuropharmacology 42, 74-81. doi: 10.1016/S0028-3908(01)00151-4
148. Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., et al. (2003). B-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br. J. Pharmacol. 139, 705-714. doi: 10.1038/sj.bjp.0705290
149. Thomson, C. G., Beer, M. S., Curtis, N. R., Diggle, H. J., Handford, E., and Kulagowski, J. J. (2004). Thiazoles and thiopyridines: novel series of high affinity h5HT7 ligands. Bioorg. Med. Chem. Lett. 14, 677-680. doi: 10.1016/j.bmcl.2003.11.050
150. To, Z. P., Bonhaus, D. W., Eglen, R. M., and Jakeman, L. B. (1995). Characterization and distribution of putative 5-HT7 receptors in guinea-pig brain. Br. J. Pharmacol. 115, 107-116. doi: 10.1111/j.1476-5381.1995.tb16327.x
151. Tomita, T., Yasui-Furukori, N., Nakagami, T., Tsuchimine, S., Ishioka, M., Kaneda, A., et al. (2014). The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder. PLoS ONE 9:e98099. doi: 10.1371/journal.pone.0098099
152. Toth, M. (2003). 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463, 177-184. doi: 10.1016/S0014-2999(03)01280-9
153. Traber, J., Davies, M. A., Dompert, W. U., Glaser, T., Schuurman, T., and Seidel, P. R. (1984). Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res. Bull. 12, 741-744. doi: 10.1016/0361-9230(84)90155-2
154. Tunnicliff, G. (1991). Molecular basis of buspirone's anxiolytic action. Pharmacol. Toxicol. 69, 149-156. doi: 10.1111/j.1600-0773.1991.tb01289.x
155. Villalobos-Molina, R., Orozco-Mendez, M., Lopez-Guerrero, J. J., and Gallardo-Ortiz, I. A. (2005). WAY 405, a new silent 5-HT1A receptor antagonist with low affinity for vascular alpha1-adrenoceptors. Auton. Autacoid. Pharmacol. 25, 185-189. doi: 10.1111/j.1474-8673.2005.00350.x
156. Waterhouse, R. N. (2003). Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol. Imaging Biol. 5, 376-389. doi: 10.1016/j.mibio.2003.09.014
157. Weiss, S., Pin, J. P., Sebben, M., Kemp, D., Sladeczek, F., Gabrion, J., et al. (1986). Synaptogenesis of cultured striatal neurones in serum-free medium: a morphological and biochemical study. Proc. Natl. Acad. Sci. U.S.A. 83, 2238-2242. doi: 10.1073/pnas.83.7.2238
158. Wesolowska, A., Nikiforuk, A., Stachowicz, K., and Tatarczynska, E. (2006). Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51, 578-586. doi: 10.1016/j.neuropharm.2006.04.017
159. Witkin, J. M., and Barrett, J. E. (1986). Interaction of buspirone and dopaminergic agents on punished behavior of pigeons. Pharmacol. Biochem. Behav. 24, 751-756. doi: 10.1016/0091-3057(86)90585-X
160. Youn, J., Hager, T., Misane, I., Pieneman, A. W., Jansen, R. F., Ögren, S. O., et al. (2013). Central 5-HT1A receptor-mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice. Br. J. Pharmacol. 170, 859-870. doi: 10.1111/bph.12325
161. Youn, J., Misane, I., Eriksson, T. M., Millan, M. J., Ögren, S. O., Meyer, M., et al. (2009). Bidirectional modulation of classical fear conditioning in mice by 5-HT1A receptor ligands with contrasting intrinsic activities. Neuropharmacology 57, 567-576. doi: 10.1016/j.neuropharm.2009.07.011